User menu

Myocardial microangiopathy associated with antiphospholipid antibodies.

Primary tabs
Add to cart
Print
Copyright (Sherpa/Romeo)
References10
Authors :
Document type : Article de périodique (Journal article) – Case Reports, Journal Article
Abstract :

Myocardial thrombotic microangiopathy is a well described post-mortem finding in patients with the catastrophic antiphospholipid (APL) syndrome. However, it has been only very rarely imaged in living patients. Here, we report two patients with APL antibodies presenting with scintigraphic, electrocardiographic and/or echocardiographic evidence of (sub)acute myocardial ischaemia, despite a normal coronary angiography. Formal proof of a thrombotic microangiopathy was obtained by a kidney biopsy in one patient. We emphasize the value of 99mTc-MIBI (2-methoxy isobutyl isonitrile) exercise stress myocardial scintigraphy for the detection of cardiac microangiopathy associated with the APL syndrome.
Access type : Accès restreint
Publication date : 2001
Journal information : "Lupus" - Vol. 10, no. 2, p. 123-5 (2001)
Peer reviewed : yes
issn : 0961-2033
Publication status : Publié
Affiliations : UCL - MD/MNOP - Département de morphologie normale et pathologique
UCL - MD/MINT - Département de médecine interne
UCL - (SLuc) Service de pathologie cardiovasculaire
MESH Subject : Adult ; Antibodies, Antiphospholipid ; Antiphospholipid Syndrome ; Coronary Disease ; Female ; Humans
Links :
Bibliographic reference Lauwerys, Bernard ; Lambert, Michel ; Vanoverschelde, Jean-Louis ; Cosyns, Jean-Pierre ; Houssiau, Frédéric. Myocardial microangiopathy associated with antiphospholipid antibodies.. In: Lupus, Vol. 10, no. 2, p. 123-5 (2001)
Permanent URL http://hdl.handle.net/2078.1/8776

References Provided by I4OC

  1. Wilson Wendell A., Gharavi Azzudin E., Koike Takao, Lockshin Michael D., Branch D. Ware, Piette Jean-Charles, Brey Robin, Derksen Ronald, Harris E. Nigel, Hughes Graham R. V., Triplett Douglas A., Khamashta Munther A., International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshop, 10.1002/1529-0131(199907)42:7<1309::aid-anr1>3.0.co;2-f
  2. Khamashta Munther A., Cuadrado Maria Jose, Mujic Fedza, Taub Nick A., Hunt Beverley J., Hughes Graham R.V., The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome, 10.1056/nejm199504133321504
  3. Asherson Ronald A., Cervera Ricard, Piette Jean-Charles, Font Josep, Lie J. T., Burcoglu Arsinur, Lim Ken, Muñoz-Rodríguez Francisco J., Levy Roger A., Boué François, Rossert Jérôme, Ingelmo Miguel, Catastrophic Antiphospholipid Syndrome: Clinical and Laboratory Features of 50 Patients : , 10.1097/00005792-199805000-00005
  4. Jouhikainen Taneli, Pohjola-Sintonen Sinikka, Stephansson Eua, Lupus Anticoagulant and Cardiac Manifestations in Systemic Lupus Erythematosus, 10.1177/096120339400300307
  5. Derumeaux G, Arch Mal Coeur Vaiss, 85, 1811 (1992)
  6. Kaplan Stuart D., Chartash Elliot K., Pizzarello Roy A., Furie Richard A., Cardiac manifestations of the antiphospholipid syndrome, 10.1016/0002-8703(92)90420-z
  7. Rojas M, Ann Cardiol Angeiol (Paris), 42, 561 (1993)
  8. Dacosta A, Arch Mal Coeur Vaiss, 86, 1773 (1993)
  9. JØRGENSEN P., HANSEN P. R., Antiphospholipid antibodies and ischaemic heart disease, 10.1111/j.1365-2796.1993.tb00990.x
  10. Kattwinkel Norman, Myocardial Infarction Caused by Cardiac Microvasculopathy in a Patient with the Primary Antiphospholipid Syndrome, 10.7326/0003-4819-116-12-974